Product overview
| Name | Torin 2 |
| Description | Potent, selective mTOR inhibitor |
| Purity | >98% |
Write Your Own Review
Biological Data
| Biological description | Potent, selective and ATP-competitive mTOR inhibitor (IC50 = 2.1 nM and EC50 value = 250 pM for inhibition of cellular mTOR activity). Shows 800-fold selectivity over PI3K and >100-fold selectivity over ~400 other protein kinases. Shows potent antiproliferative activity. Causes apoptosis and autophagy and induces G0/G1 cell cycle arrest. |
Solubility & Handling
| Storage instructions | +4°C |
| Important | This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
Chemical Data
| Chemical name | 9-(6-Amino-3-pyridinyl)-1-[3-(trifl uoromethyl)phenyl]-benzo[h]-1,6-naphthyridin-2(1H) -one |
| Molecular Weight | 432.4 |
| Molecular Formula | C24H15F3N4O |
| CAS Number | 1223001-51-1 |
| PubChem identifier | 51358113 |
| SMILES | O=C(C=C3)N(C5=CC=CC(C(F)(F)F)=C5)C2=C3C=NC1=CC=C(C4=CC=C(N)N=C4)C=C12 |
| InChiKey | GUXXEUUYCAYESJ-UHFFFAOYSA-N |
References for Torin 2
References are publications that support the biological activity of the product
-
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation.
Simioni et al (2014) Oncotarget 5(20) : 10034-47 -
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR.
Liu et al (2013) Cancer Res 73(8) : 2574-86 -
Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer.
Liu et al (2011) J Med Chem 54(5) : 1473-80
Understanding purity and quality - a guide for life scientists